Drawing for EPICORE

USPTO serial 88164402

EPICORE

Reviewed by CopyMark Law Group

Reg. 5916403Status 702Registered
Filing date
Status date
Registration date
Nov 19, 2019
Examiner
NUNLEY, CHRISTOPHER MICHAEL
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with EPICORE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Thomas K. Cox

Thomas K. Cox MCCARTHY DUFFY LLP180 NORTH LASALLE STREET, SUITE 3150CHICAGO, IL 60601United States

Goods and services

ClassDescriptionStatusFirst use
009Apparatus for application to the skin for testing and analyzing body fluids and other physiological dataACTIVEJan 22, 2018
010Medical device for application to the skin for testing and analyzing body fluids and other physiological dataACTIVEJan 22, 2018

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 19, 2026NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Feb 19, 2026C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Feb 19, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Nov 14, 2025E815TEAS SECTION 8 & 15 RECEIVED—
Nov 19, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Nov 19, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 15, 2019SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Oct 12, 2019CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Sep 22, 2019SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Sep 22, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Sep 3, 2019IUAFUSE AMENDMENT FILED—
Sep 3, 2019EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
May 7, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 12, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 12, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 20, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 31, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 30, 2019DOCKASSIGNED TO EXAMINER—
Nov 2, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 25, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance